article 3 months old

DCA Group Out Of Favour Following Earnings Disappointment

Australia | May 12 2006

By Chris Shaw (Tokyo)

If management teams at listed companies understand one thing, it is to try to avoid disappointing the market in terms of earnings expectations because the impact of such an outcome is never pretty in terms of the effect on the share price.

The latest to endure such an experience is DCA Group (DVC), which yesterday revised down its earnings guidance for the current year to the bottom of its previously indicated target range.

At first glance it might seem such a revision to guidance is nothing too serious given it is within previously indicated limits, but such an opinion would seem at odds with the broader market considering the stock has been marked down by more than 15% as a result.

Management has suggested full year earnings will now be around the $75m mark against $75-85m previously, citing slowing revenue and margin pressure. Brokers have responded by reducing their estimates in line with the new guidance, many taking the opportunity to lower their rating on the stock as a result.

Deutsche Bank has been the harshest judge, cutting its recommendation to Sell from Hold and lowering its target price to $3.10 from $3.60. In the broker’s view, the higher wage costs the company is experiencing are likely to continue into next year so there is little relief in sight for the margin pressure being experienced.

It is positive on the group’s proposed acquisition of Regis Group and the likelihood this would result in a spin-off of the group’s property assets, but points out the impact on earnings is not enough to offset the margin pressure and slowing revenues.

Macquarie too has taken the axe to its rating, bringing it to Neutral from Buy with a target price of $3.65. It too sees a positive impact from the potential to spin-off the property assets, but estimates it is likely to lift ROE (return on equity) by around 1% only.

Merrill Lynch has similarly downgraded the stock, pointing out there is nothing to suggest the current pressure on earnings will moderate in the short-term.

UBS’s rating is virtually unchanged at Neutral 2 compared to Neutral 1 previously, the broker suggesting the government’s review of the diagnostic imaging sector is likely to have a greater impact on sentiment than actual earnings.

The broker too has cut its forecasts following the revised guidance, but prefers to look at the upside potential of increasing its total aged care beds by as much as 45% through the Regis Group acquisition. UBS also sees the potential for upside from winning contracts in the UK, which it estimates could add as much to 50c to its valuation. Its target price now stands at $3.95 from $4.00 previously.

JP Morgan and ABN Amro have taken an opposite stance, both retaining their respective Overweight and Buy rating. JP Morgan has not adjusted its valuation of $3.83 as the revised guidance was in line with its normalised earnings forecasts, but ABN has dropped its target to $4.15 from $4.34 on account of the lower earnings expectations. JP Morgan also sees potential for upside from the winning of new contracts in the UK, but points out there is now some additional pressure for management to deliver on FY07 expectations given costs in the radiology operations are increasing.

The FN Arena database shows the stock is rated as Buy twice and Accumulate once, compared to four Hold ratings and one Sell. The average target price for the company is around $3.90, which compares to a current market price of around $3.17, down from yesterday’s close of $3.80.

Including the recommendation downgrade at Credit Suisse, four days ago, DCA has now received four downgrades this week. It’s reading on the FN Arena Market Sentiment Indicator has dropped from +0.7 to +0.2.

To share this story on social media platforms, click on the symbols below.

Click to view our Glossary of Financial Terms

Australian investors stay informed with FNArena – your trusted source for Australian financial news. We deliver expert analysis, daily updates on the ASX and commodity markets, and deep insights into companies on the ASX200 and ASX300, and beyond. Whether you're seeking a reliable financial newsletter or comprehensive finance news and detailed insights, FNArena offers unmatched coverage of the stock market news that matters. As a leading financial online newspaper, we help you stay ahead in the fast-moving world of Australian finance news.